Cargando…
THU004 Impact Of Continuous Medical Education At Improving Knowledge And Confidence Related To New And Emerging Pediatric Growth Hormone Deficiency Treatment Options
Disclosure: A. Larkin: None. C. Capparelli: None. B.S. Miller: Advisory Board Member; Self; Abbvie, Vertice, Ascendis, Bristol-Myers Squibb, Biomarin, Tolmar, Novo Nordisk, Pfizer, Inc. Research Investigator; Self; Abbvie, Amicus, Aeterna Zentaris, Amgen Inc, OPKO, Alexion Pharmaceuticals, Inc., Lum...
Autores principales: | Larkin, Amy, Capparelli, Catherine, Miller, Bradley Scott, Geffner, Mitchell E, Silverman, Lawrence A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554257/ http://dx.doi.org/10.1210/jendso/bvad114.1380 |
Ejemplares similares
-
THU159 Identifying Causative Genes For Pituitary Hormone Deficiencies
por: Mayer, Julian Martinez, et al.
Publicado: (2023) -
THU172 Accuracy Of The Glucagon Testing In The Diagnosis Of Growth Hormone Deficiency During Transition
por: Di Iorgi, Natascia, et al.
Publicado: (2023) -
THU177 Brain Magnetic Resonance Imaging Abnormalities And Effect On Growth Response In Children With Growth Hormone Deficiency
por: Choe, Jaewon, et al.
Publicado: (2023) -
THU173 Subanalysis By Tanner Stage In Phase 3 Trials In Children And Adolescents With Growth Hormone Deficiency Treated With Lonapegsomatropin
por: Hofman, Paul, et al.
Publicado: (2023) -
THU166 A Minimum Data Set For The Monitoring Of Recombinant Human Growth Hormone (rhGH) Therapy In Children With Growth Hormone Deficiency (GHD)—A GloBE-Reg Initiative
por: Chen, Suet Ching, et al.
Publicado: (2023)